Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Mouton

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Infection|July 8, 2000
Combination therapy as a tool to prevent emergence of bacterial resistanceJ W Mouton
The Journal of Antimicrobial Chemotherapy|March 27, 2001
Use of the t > MIC to choose between different dosing regimens of beta-lactam antibioticsJ W Mouton, N Punt
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 27, 2001
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the NetherlandsJ W Mouton, A R Jansz
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991
Susceptibility to various antimicrobial agents and tolerance to methicillin of Staphylococcus aureus isolates from cystic fibrosis patientsA M Horrevorts, J W Mouton
The Journal of Antimicrobial Chemotherapy|July 1, 1996
Is continuous infusion of beta-lactam antibiotics worthwhile?--efficacy and pharmacokinetic considerationsJ W Mouton, A A Vinks
Nederlands Tijdschrift Voor Geneeskunde|November 27, 1993
[Antimicrobial treatment using beta-lactam antibiotics: continuous infusion appears to be sensible]J W Mouton, A A Vinks
The Medical Clinics of North America|May 1, 1990
Antibacterial therapy in cystic fibrosisJ W Mouton, K F Kerrebijn
The Journal of Antimicrobial Chemotherapy|December 1, 1991
Pharmacokinetics of meropenem in serum and suction blister fluid during continuous and intermittent infusionJ W Mouton, M F Michel
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1993
Abnormal pharmacokinetics: the need for monitoringA M Horrevorts, J W Mouton
Antimicrobial Agents and Chemotherapy|May 1, 1994
Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic modelJ W Mouton, J G den Hollander
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Infection|July 8, 2000
Combination therapy as a tool to prevent emergence of bacterial resistanceJ W Mouton
The Journal of Antimicrobial Chemotherapy|March 27, 2001
Use of the t > MIC to choose between different dosing regimens of beta-lactam antibioticsJ W Mouton, N Punt
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 27, 2001
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the NetherlandsJ W Mouton, A R Jansz
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991
Susceptibility to various antimicrobial agents and tolerance to methicillin of Staphylococcus aureus isolates from cystic fibrosis patientsA M Horrevorts, J W Mouton
The Journal of Antimicrobial Chemotherapy|July 1, 1996
Is continuous infusion of beta-lactam antibiotics worthwhile?--efficacy and pharmacokinetic considerationsJ W Mouton, A A Vinks
Nederlands Tijdschrift Voor Geneeskunde|November 27, 1993
[Antimicrobial treatment using beta-lactam antibiotics: continuous infusion appears to be sensible]J W Mouton, A A Vinks
The Medical Clinics of North America|May 1, 1990
Antibacterial therapy in cystic fibrosisJ W Mouton, K F Kerrebijn
The Journal of Antimicrobial Chemotherapy|December 1, 1991
Pharmacokinetics of meropenem in serum and suction blister fluid during continuous and intermittent infusionJ W Mouton, M F Michel
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1993
Abnormal pharmacokinetics: the need for monitoringA M Horrevorts, J W Mouton
Antimicrobial Agents and Chemotherapy|May 1, 1994
Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic modelJ W Mouton, J G den Hollander
Pageof 14